Global Coagulation Reagents Market – Industry Trends and Forecast to 2029

Coagulation Reagents Market Analysis and Size

Reagents are primarily used for the rapid diagnosis of various diseases caused by abnormal blood clotting/fibrinolysis, as well as more reliable reagents for measuring coagulation/fibrinolysis factors, activators, and/or inhibitors, which are useful in determining the course of treatment. Coagulation reagents with high stability for cost efficiency are applicable to a wide range of clinical chemistry analytical devices. Customer-specific reagents for coagulation-based in-vitro diagnostic devices are also researched and developed. Certain models are soluble in aqueous buffers or water and are intended for use with human plasma in thrombin clotting time tests.

Data Bridge Market Research analyses that the coagulation reagents market which was USD 2,738.84 million in 2021, is expected to reach USD 6176.57 million by 2029, and a CAGR of 10.7% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Coagulation Reagents Market Scope and Segmentation      

Market Definition

Coagulation test systems consist of an instrument as well as a reagent (thromboplastin or partial thromboplastin). Coagulation tests assess the ability of blood to clot as well as the time it takes to clot. Tests can assist doctors in determining the likelihood of excessive bleeding or clot formation (thrombosis) anywhere in the blood vessels. Coagulation reagents are excellent for measuring large areas in order to detect abnormal results accurately, and they have strong correlations with standard methods, ensuring that results are reliable.

Global Coagulation Reagents Market Dynamics

Drivers

• Rising incidence of cardiovascular diseases

Rising incidence of cardiovascular illnesses and blood disorders is likely to have a substantial impact on the coagulation reagents market in the forecast period of 2022 to 2029. Cardiovascular diseases (CVDs) are becoming more prevalent in the Indian population, with a trend toward younger age groups. It is known to play a significant role in burden of diseases. A number of studies have been conducted to determine the prevalence of CVDs, and it has been discovered that they are widespread in India, with regional variations.

Another important factor driving the expanding use of blood coagulation analyzers is the growing senior population, rising healthcare costs, technological developments, and rising obesity rates. Emerging markets and the growing reagent rental business, on the other hand, will provide significant chances for the coagulation reagents market to grow throughout the forecast period.

• New innovative technologies

The introduction of innovative analyzers by key market players that are tiny and simple to integrate has risen a demand for such analyzers to be widely used in a variety of medical facilities. Furthermore, the increasing awareness of the health-care system in many parts of the world is increasing demand for such analyzers. The overall industry is also being propelled by rapid advancements and optimization in testing facilities.

• Demand for healthcare funds

Proliferation of innovative health care facilities, treatment centres, laboratory facilities, and academic institutions that have followed has resulted in a significant increase in demand for this type of analyzer. Demand for these analyzers is also increasing due to an increase in the number of heart attacks and blood diseases. Patients were able to utilise these analyzers at home to assess their coagulation state due to their convenience of use and performance features. The above-mentioned factors are expected to enhance worldwide market growth.

Opportunities

• Government initiatives

The initiatives by the government and corporations resulted in people going for early diagnosis. For instance, Boehringer Ingelheim hosted a symposium in November 2014 to discuss treatment safety and efficacy in acute Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). As a result, the demand for haematological tests has increased, and the demand for coagulation reagents also increasing.

Restraints/Challenges

High cost, strict and time-consuming regulatory processes will obstruct the market's growth rate.  One of the major disadvantages of using chemical coagulation is the large amount of residual sludge produced at the end of the process. Electrocoagulation generates about half the sludge that chemical coagulation does. Several countries now have strict legislation in place to limit the environmental impact of such residuals.

This coagulation reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the coagulation reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Coagulation Reagents Market

The sudden increasing cases of COVID-19 have caused increased consciousness of the population across the globe towards health. People are avoiding the products that do not come under essential commodities owing to the demand for these analyzers has been decreased. Moreover, the reduced supply chain affected the production and supply of the coagulation analyzer. Furthermore, due to disease severity and poor diagnosis of COVID-19 coagulation parameters are associated with it and is considered to be a risk factor for COVID-19. 

Global Coagulation Reagents Market Scope

The coagulation reagents market is segmented on the basis of test type, technology and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• APTT
• D-Dimer
• Fibrinogen
• Prothrombin
• Others

 Technology

• Mechanical
• Electrochemical
• Optical
• Others

 End Use

• Hospitals
• Research Institutes
• Diagnostic Centers
• Others

Coagulation Reagents Market Regional Analysis/Insights

The coagulation reagents market is analysed and market size insights and trends are provided by country, test type, technology and end use as referenced above.

The countries covered in the coagulation reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the coagulation reagents market due to the increasing government initiatives for the development of healthcare infrastructure in the region and rising incidence of blood-related disorders, increasing prevalence of disorders.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the growing number of hospitals, health centers and clinics combined with highly skilled professionals to provide useful, appropriate and safe healthcare facilities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Coagulation Reagents Market Share Analysis

The coagulation reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to coagulation reagents market.

Some of the major players operating in the coagulation reagents market are:

• Sclavo Vaccines Association (Italy)
• Randox Laboratories Ltd. (U.K.)
• BIO DIAGNOSTICS Ltd. (U.K.)
• Robonik India (India)
• Sekisui Diagnostics (U.S.)
• Haemonetics Corporation (U.S.)
• Agappediagnostics Ltd. (India)
• Rayto Life and Analytical Sciences Co. Ltd. (China)
• China BeiJing Steellex Scientific Instrument Company (China)
• Siemens (Germany)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Gesan Production (Italy)
•  Goldsite Diagnostics Inc. (China)
• Grifols S.A (Spain)
•  Diagnostica Stago (France)
•  High Technology, Inc. (U.S.)
•  Bio Group Medical System (Italy)
•  Zircon Biotech Co., Ltd (China)
• McGraw Hill (U.S.)

SKU-55737